Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVM
4101
Silvercorp Metals
SVM
$2.68B
| $3.7M | ﹤0.01% |
956,936
-182,343
| -16% | -$641K |
|
4102
Aclaris Therapeutics
ACRS
$860M
| $3.7M | ﹤0.01% |
2,415,584
+1,343,800
| +125% | +$2.87M |
|
|
PHK
4103
PIMCO High Income Fund
PHK
$875M
| $3.7M | ﹤0.01% |
755,767
-20,572
| -3% | -$101K |
|
4104
Global Industrial
GIC
$1.49B
| $3.69M | ﹤0.01% |
164,852
+970
| +0.6% | +$23.2K |
|
|
MLNK
4105
DELISTED
MeridianLink
MLNK
| $3.69M | ﹤0.01% |
199,058
-47,819
| -19% | -$924K |
|
|
BGH
4106
Barings Global Short Duration High Yield Fund
BGH
$285M
| $3.68M | ﹤0.01% |
243,567
-39,787
| -14% | -$624K |
|
4107
Ennis
EBF
$556M
| $3.68M | ﹤0.01% |
183,070
-44,829
| -20% | -$931K |
|
4108
Orthofix Medical
OFIX
$415M
| $3.67M | ﹤0.01% |
224,820
-400,231
| -64% | -$7.03M |
|
4109
Zegna
ZGN
$3.76B
| $3.67M | ﹤0.01% |
495,440
+284,826
| +135% | +$2.35M |
|
4110
Absci
ABSI
$1.62B
| $3.66M | ﹤0.01% |
1,457,835
+995,688
| +215% | +$3.65M |
|
|
TDF
4111
Templeton Dragon Fund
TDF
$274M
| $3.65M | ﹤0.01% |
376,339
-78,395
| -17% | -$720K |
|
4112
Cullinan Oncology
CGEM
$1.26B
| $3.65M | ﹤0.01% |
481,832
-156,237
| -24% | -$1.5M |
|
4113
Invesco S&P SmallCap Health Care ETF
PSCH
$171M
| $3.64M | ﹤0.01% |
84,062
-3,255
| -4% | -$147K |
|
4114
Heritage Insurance Holdings
HRTG
$980M
| $3.63M | ﹤0.01% |
251,730
+78,457
| +45% | +$943K |
|
|
OPPJ
4115
WisdomTree Trust WisdomTree Japan Opportunities Fund
OPPJ
$290M
| $3.63M | ﹤0.01% |
103,705
-1,617
| -2% | -$55.7K |
|
4116
iShares Morningstar Multi-Asset Income ETF
IYLD
$126M
| $3.63M | ﹤0.01% |
180,748
-7,581
| -4% | -$151K |
|
4117
Ginkgo Bioworks
DNA
$488M
| $3.62M | ﹤0.01% |
635,719
+70,447
| +12% | +$718K |
|
4118
Camden National
CAC
$990M
| $3.62M | ﹤0.01% |
89,489
-24,853
| -22% | -$1.07M |
|
4119
Corporacion America
CAAP
$6.43B
| $3.61M | ﹤0.01% |
197,294
-114,922
| -37% | -$2.17M |
|
|
BRY
4120
DELISTED
Berry Corp
BRY
| $3.59M | ﹤0.01% |
1,118,576
+111,962
| +11% | +$459K |
|
4121
Ferrovial N.V. Ordinary Shares
FER
$46.5B
| $3.59M | ﹤0.01% |
80,603
+14,211
| +21% | +$613K |
|
4122
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$344M
| $3.58M | ﹤0.01% |
212,035
-5,783
| -3% | -$102K |
|
4123
Capital Southwest
CSWC
$1.61B
| $3.57M | ﹤0.01% |
159,798
-53,650
| -25% | -$1.21M |
|
4124
CNB Financial Corp
CCNE
$1.04B
| $3.56M | ﹤0.01% |
160,179
-46,382
| -22% | -$1.13M |
|
4125
Willdan Group
WLDN
$1.29B
| $3.56M | ﹤0.01% |
87,500
+19,056
| +28% | +$705K |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.